A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/1999
12/29/1999	WO1999057140A3 Growth-associated protease inhibitor heavy chain precursor
12/29/1999	WO1999055715A3 Polysaccharide-antigen conjugates
12/29/1999	WO1999042564A3 Apoptotic cell-mediated antigen presentation to dendritic cells
12/29/1999	WO1998055150A8 Txu-7-pap immunotoxin and use thereof
12/29/1999	WO1997040147A8 Antigenically reactive regions of the hepatitis a virus polyprotein
12/29/1999	EP0967279A1 Helicobacter pylori cytotoxin useful for vaccines and diagnostics
12/29/1999	EP0967277A2 Production of chimeric mouse-human antibodies with specificity to human tumor antigens
12/29/1999	EP0967242A2 Bioactive polymers having fixed immune adjuvants
12/29/1999	EP0967223A2 Hepatitis C virus peptide antigens and a method of testing for the hepatitis C virus (HCV)
12/29/1999	EP0966970A1 Antigen specific to meniere's disease and medical use thereof
12/29/1999	EP0966545A2 Method for typing of minor histocompatibility antigen ha-1
12/29/1999	EP0966538A1 Replication-competent recombinant sabin type 1 strain of poliovirus
12/29/1999	EP0966537A2 AN $i(EX VIVO) ANIMAL OR CHALLENGE MODEL AS METHOD TO MEASURE PROTECTIVE IMMUNITY DIRECTED AGAINST PARASITES AND VACCINES SHOWN TO BE PROTECTIVE IN SAID METHOD
12/29/1999	EP0966535A1 Epitopes of the protein pre-m/m of the dengue virus, synthetic peptides
12/29/1999	EP0966527A1 Method for inducing mutations and the use thereof in the production of a vaccine against pathogenic microorganisms
12/29/1999	EP0966484A1 Neurotactin and uses therefor
12/29/1999	EP0966302A1 Methods of therapeutic administration of anti-cd40l compounds
12/29/1999	EP0966301A1 Identification of human cytomegalovirus genes involved in down-regulation of mhc class i heavy chain expression
12/29/1999	EP0966300A1 Treatment of autoimmune diseases, including aids
12/29/1999	EP0966296A1 Conjugated peptides, immunological reagent containing same and use thereof for treatment of immunological disorders
12/29/1999	EP0966196A1 Composition for organ cryopreservation and treatment of viral and bacterial infections
12/29/1999	EP0751788B1 Composition including a recombinant plasmid, and uses thereof as a vaccine and drug
12/29/1999	EP0668781B1 Lymphokine gene therapy of cancer in combination with tumor antigens
12/29/1999	EP0635062B1 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS OF mRNA
12/29/1999	EP0556292B1 Hepatitis c virus asialoglycoproteins
12/29/1999	CN1240001A Mutants of streptococcal toxin C and methods of use
12/29/1999	CN1240000A Polypeptides encoded by human lipase-like gene, compositions and methods
12/29/1999	CN1239997A Methods of preserving prokaryotic cells and compositions obtained thereby
12/29/1999	CN1239675A Anti-tumor agent comprising salmosin as active ingredient
12/29/1999	CA2690395A1 Use of bi-specific antibodies for pre-targeting diagnosis and therapy
12/29/1999	CA2334767A1 Process for the in vitro replication of hcv
12/29/1999	CA2333750A1 Adjuvant therapy
12/29/1999	CA2331923A1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses
12/29/1999	CA2331769A1 Prostate cancer-associated genes
12/29/1999	CA2330526A1 Particles of hcv envelope proteins: use for vaccination
12/29/1999	CA2330249A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides
12/29/1999	CA2330189A1 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore
12/29/1999	CA2330178A1 Synthetic peptide vaccines for foot-and-mouth disease
12/29/1999	CA2329755A1 Synthetic somatostatin immunogen for growth promotion in farm animals
12/29/1999	CA2294075A1 Herbal extract composition and method with immune-boosting capability
12/28/1999	US6008434 Rodents with mutated endogenous growth differentiation factor-11 gene; animals exhibiting a phenotype of increased muscle tissue; animal food products with high muscle and protein content, reduced fat and cholesterol
12/28/1999	US6008342 A dna encoding an immunogenic polypeptide; coccidiosis vaccines in poultry
12/28/1999	US6008340 Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules
12/28/1999	US6008337 Polynucleotides encoding polypeptides; diagnosis and therpy for acquired immune disease syndrome, gout, addison's/crohn's diseases, adult respiratory distress syndrome, multiple sclerosis; antiarthritic/anticarcinogenic/antidiabetic agents
12/28/1999	US6008336 Compacted nucleic acids and their delivery to cells
12/28/1999	US6008326 A monospecific antigen protein of haemophililus influenzae; therapy for ear infections, meningitis, pneumonia, and oral diseases
12/28/1999	US6008325 An antibody specific for a trimeric alpha-homotrimer propeptide; therapy for osteoporosis, rheumatic diseases; anticarcinogenic/antiarthritic agents
12/28/1999	US6008201 DNA molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
12/28/1999	US6008050 A polynucleotide encoding a polypeptide related to g protein coupled 7 transmembrane receptors; diagnosis/therapy of heart diseases, osteoporosis, anxiety, eating disorders, schizophrenia, ulcers, parkinson's/huntington's disease
12/28/1999	US6008044 Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) and detection of antibodies against epitope (GCSGKLIC)
12/28/1999	US6008042 A polynucleotide; diagnosis and therapy for stroke, septic shock, acquired immune deficiency syndrome, osteoporosis, antiarthritic/antiinflammatory/antiischemic agents, genetic disorders; alzheimer's/parkinson's diseases
12/28/1999	US6008036 Introducing the viruses in cell culture medium onto an anion exchange chromatography column, eluting the virus of interest then introducing the eluted virus into a cation exchange chromotography column, eluting purified virus; vaccines
12/28/1999	US6008030 A polynucleotide sequences encoding a protein; therapy and diagnosis of infections, respiratory and gastrointestinal disorders; toxic shock syndrome; antiarthritic and anticarcinogenic agents
12/28/1999	US6008023 Producing a fusion protein by transforming a thioredoxin reductase-deficient escherichia with a nucleotide molecule encoding an antibody or fragment; culturing and expressing the antibody; isolating antibody from the cytoplasm
12/28/1999	US6008017 Human cardiac/brain tolloid-like protein
12/28/1999	US6007838 Process for making liposome preparation
12/28/1999	US6007825 Serpulina hyodysenteriae vaccine comprising a tly gene mutant
12/28/1999	US6007824 Orally administering synergistic mixture of l-arginine, ginseng and zizyphi fructus to stimulate release of nitrogen monoxide and cause smooth muscle relaxation in human body
12/28/1999	US6007819 Administering to mammal an antigen and a dipeptide-derivative to induce immunoglobulin g immune response; vaccines
12/28/1999	US6007818 Oligosaccharide derived from an antigenic polysaccharide obtained from a pathogenic agent
12/28/1999	US6007815 Immunology
12/28/1999	US6007807 Hybrid fusion cell comprising idiotypic antibody-expressing malignant b cell fused to b cell hybridoma expressing an antibody which is internalized on an antigen presenting cell
12/28/1999	US6006752 Mixed chimerism and tolerance
12/28/1999	CA2143163C Peptides derived from a retrovirus of the hiv group, and their use
12/28/1999	CA1340863C Domain-modified constant region antibodies
12/23/1999	WO1999066049A2 A novel gene and method of treating a gram negative bacterial infection
12/23/1999	WO1999066048A1 A mutant human hepatitis b viral strain and uses thereof
12/23/1999	WO1999066047A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999	WO1999066046A1 Hiv virus mimotopes
12/23/1999	WO1999066045A1 Newcastle disease virus infectious clones, vaccines and diagnostic assays
12/23/1999	WO1999066043A1 Recombinant production of toxoplasma sag1 antigen
12/23/1999	WO1999066041A1 94 human secreted proteins
12/23/1999	WO1999066025A2 Mtbx protein and nucleic acid molecules and uses therefor
12/23/1999	WO1999065947A2 Monoclonal antibodies directed against the g3bp protein, and uses
12/23/1999	WO1999065939A1 INTERACTION OF p27(KIP1) WITH FKBP-12
12/23/1999	WO1999065924A2 Preparation and use of superior vaccines
12/23/1999	WO1999065871A2 Thiolesters and uses thereof
12/23/1999	WO1999065530A1 NrdD
12/23/1999	WO1999065523A1 Immunotherapeutic composition and method for the treatment of prostate cancer
12/23/1999	WO1999065522A1 Hla binding peptides and their uses
12/23/1999	WO1999065521A1 Methods and materials for the treatment of prostatic carcinoma
12/23/1999	WO1999065520A1 Egg surface proteins and methods for use for modulating fertility
12/23/1999	WO1999065518A2 Lt and ct in parenteral immunization methods against helicobacter infection
12/23/1999	WO1999065517A2 Therapeutic compositions that produce an immune response by altering the antigen
12/23/1999	WO1999065507A1 Modulating platelet function
12/23/1999	WO1999065461A2 Cationic amphiphile micellar complexes
12/23/1999	WO1999053960A3 Enhancing immune responses to genetic immunization by using a chemokine
12/23/1999	WO1999049876A3 Bacterial or yeast extracts which stimulate the production of defensins and methods of use thereof
12/23/1999	WO1999047558A3 T cell costimulatory proteins, sequences and uses thereof
12/23/1999	WO1999047168A3 Induction and enhancement of the immune response to type-2 t cell-independent antigens conjugated to lipid or lipid-containing moieties
12/23/1999	WO1999045098A3 Delivery or proteins into eukaryotic cells with recombinant yersinia
12/23/1999	WO1999033869A3 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
12/23/1999	DE19852804C1 Pharmaceutical composition for manipulating angiogenesis
12/23/1999	DE19822122A1 Humane deadenylierende Nuclease, ihre Herstellung und Verwendung Human deadenylierende nuclease, their preparation and use
12/23/1999	CA2335638A1 Cationic amphiphile micellar complexes
12/23/1999	CA2335487A1 Lt and ct in parenteral immunization methods against helicobacter infection
12/23/1999	CA2335464A1 Novel thiolesters and uses thereof
12/23/1999	CA2335452A1 Preparation and use of superior vaccines
12/23/1999	CA2335337A1 Methods and materials for the treatment of prostatic carcinoma
12/23/1999	CA2334165A1 Newcastle disease virus infectious clones, vaccines and diagnostic assays

1 ... 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 ... 1823